Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

A biliary metal stent is defined as a flexible metallic tube, specially designed to hold the bile duct open, which has been partially or fully blocked. In the bile duct, as the blockage occurs, fluids like bilirubin (bile) are unable to flow smoothly into the duodenum that aids digestion. The technological advancements in biliary disorder treatment are expected to drive the growth of the global metal non-covered biliary stent market.

Key players in the industry are investing in research & development and commercialization of products for treatment of biliary disorders, which is expected to boost the growth of the global metal non-covered biliary stent market during the forecast period. Additionally, the rising geriatric population and increasing R&D funding are propelling market growth. For instance, according to the World Health Organization (WHO), the global proportion of 60 years and older population was 12% in 2015 and is expected to increase to 22% by 2050. Thus, in 2015, the world's geriatric population was 900 million and this number is estimated to increase to 2 billion by 2050.

Global Metal Non-Covered Biliary Stent Market -  Impact of Coronavirus (Covid-19) Pandemic

The metal non-covered biliary stent market growth has been affected significantly due to the outbreak of COVID-19 as researchers and industry players are facing challenges in performing clinical trials during the pandemic. The metal non-covered biliary stent market is expected to regain momentum due to factors such as well-researched market strategies by key players and supportive government regulations.

The all-inclusive version of the report will include the impact of COVID-19 and the probable changes in the future outlook of the industry, by taking into account the technological, social, political, and economical parameters.

The metal non-covered biliary stent market is estimated to be valued at US$ 326.31 million in 2020 and is expected to register a CAGR of 4.4% during the forecast period (2020-2027).

Figure 1: Global Metal Non-Covered Biliary Stent Market Share (%) Analysis, By Type, 2020

Metal Non-Covered Biliary Stent  | Coherent Market Insights

The increasing research & development activities and product launches are expected to propel the growth of metal non-covered biliary stent market.

Key players in the market are investing in research & development and of novel products to strengthen their position in the metal non-covered biliary stent market, as supporting clinical evidences would accelerate the adoption of these stents.

For instance, according to a study published in the Journal of the American Medical Association (AMA) in March 2016, the placement of self-expanding metallic stent (cSEMS), which is a single covered biliary stent via ERCP (Endoscopic Retrograde Cholangiopancreatography) resolved benign restrictions of the pancreatic and biliary ducts. These factors are expected to propel growth of the metal non-covered biliary system market.

Furthermore, key industry players are adopting several strategies such as collaborations and joint agreements. For instance, in June 2018, Cook Medical partnered with Taewoong Medical to distribute its existing line of metal stents in the U.S. This new partnership includes the Niti-S through the Scope (TTS) Esophageal Stent, which is the flagship product of Taewoong’s Niti-S Self-Expandable line of metal gastrointestinal stents. Cook will be also be the distributor for Niti-S Biliary Stent in the U.S.

Moreover, in May 2019, Q3 Medical Devices Limited entered a distribution agreement with Medtronic Plc for its AECHIMEDES, a biodegradable biliary and pancreatic stent. This stent is specially designed as an alternative to the traditional plastic biliary stents. The aim behind this six-year exclusive agreement is to distribute ARCHIMEDES biodegradable stent in the western EU, Japan, and the U.S. with rights to other regions.

request-sample

Metal Non-Covered Biliary Stent Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 326.31 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 4.4% 2027 Value Projection: US$ 440.70 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Adsorbable, Non-Adsorbable.
  • By Application: Malignant Obstruction, Biliary Leaks, Benign Biliary Strictures, Others.
  • By End User: Hospitals, Clinics, Ambulatory Surgical Centers.
Companies covered:

Boston Scientific, AMG International, C.R. Bard, Merit Medical, Cook Medical, PNN Medical, Teleflex, and Taewoong Medical

Growth Drivers:
  • Technological advancements
  • The growing geriatric population across the globe
Restraints & Challenges:
  • High cost of biliary stent insertion procedures
  • The rising adoption of substitutes for biliary surgeries

Global Metal Non-Covered Biliary Stent Market - Restraints

High cost associated with the stent insertion procedure is a major factor which is expected to hamper the growth of the global metal non-covered biliary stent market. Moreover, the rising adoption of substitutes for biliary surgeries is also expected to be a major threat to the growth of the metal non-covered biliary stent market.

Global Metal Non-Covered Biliary Stent Market – Regional Analysis

North America accounted for the highest share in the metal non-covered biliary stent market in 2019 and is expected to retain its dominance during the forecast period due to the growing healthcare expenditure and FDA approvals in the region. For instance, in March 2019, BrightWater Medical Inc. received the U.S. FDA approval for its ConvertX Biliary stents for the treatment of biliary duct obstructions. ConvertX is the first system to provide an option of percutaneous plastic biliary to interventional radiologists.

Moreover, strong presence of major market players and an increasing number of product launches are other factors responsible for the regional market growth. For instance, in June 2020, Cook Medical launched two products; Zilver 635 Biliary Stent and Transluminal Biliary Biopsy Forceps in the U.S. for biliary duct procedures. These products are introduced in the market to restore the natural flow of the duct systems.

Furthermore, the market in Asia Pacific is projected to witness significant CAGR during the forecast period owing to research & development activities and government initiatives in the treatment of bile duct disorder. For instance, the Ministry of Health and Family Welfare, India is taking initiatives such as Infection Prevention and Control Programs which include bile duct, liver or pancreatic disorder surgeries.

Figure 2: Metal Non-Covered Biliary Stent Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Metal Non-Covered Biliary Stent  | Coherent Market Insights

Global Metal Non-Covered Biliary Stent Market - Competitive Landscape

Key players operating in the global metal non-covered biliary stent market are Boston Scientific, AMG International, C.R. Bard, Merit Medical, Cook Medical, PNN Medical, Teleflex, and Taewoong Medical.

A biliary stent is a metal or plastic tube inserted into a duct or lumen to keep the passage open. The metal biliary stent is a flexible metallic tube designed to hold the blocked bile duct open. These stents have numerous applications such as leaking of the bile duct, biliary strictures, and malignant biliary obstruction. In pancreatic cancer, the metal non-covered biliary stent has higher rate of tissue growths and lower risk for cholecystitis. Furthermore, these stents are non-removable and advantageous due to the increased diameter of the stent which reduces recurrent obstruction.

Market Dynamics

The growing geriatric population and high prevalence of biliary diseases is driving the growth of the global metal non-covered biliary stent market. For instance, as per the World Health Organization (WHO) statistics, the global geriatric population was 900 million in 2015 and is likely to reach 2 billion by the end of 2050. Furthermore, increasing research & development funding is expected to propel the market growth during the forecast period.

Technological advancements in the treatment of biliary disorders and the growing healthcare expenditure in emerging economies is estimated to fuel the market growth during the forecast period. Moreover, key players are involved in research & development, and commercialization of novel biliary stents. For instance in May 2015, Taewoong Medical developed KAFFES Biliary Stent System, which is used for the management of anastomotic strictures, and BUMPY Biliary Stents that are used for the management of pancreatic strictures and other protocols. However, high costs related to biliary stent insertion and availability of substitutes to metal non-covered biliary stents are expected to restrict the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global metal non-covered biliary stent market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global metal non-covered biliary stent market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study are C.R. Bard, AMG International, Boston Scientific, PNN Medical, Cook Medical, Taewoong Medical, Merit Medical, and Teleflex
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global metal non-covered biliary stent market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the metal non-covered biliary stent market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Metal Non-covered Biliary Stent Market, By Type:
    • Adsorbable
    • Non-adsorbable
  • Global Metal Non-covered Biliary Stent Market, By Application:
    • Malignant Obstruction
    • Biliary Leaks
    • Benign Biliary Strictures
    • Others
  • Global Metal Non-covered Biliary Stent Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • Global Metal Non-covered biliary stent Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Type:
        • Adsorbable
        • Non-adsorbable
      • By Application:
        • Malignant Obstruction
        • Biliary Leaks
        • Benign Biliary Strictures
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Type:
        • Adsorbable
        • Non-adsorbable
      • By Application:
        • Malignant Obstruction
        • Biliary Leaks
        • Benign Biliary Strictures
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Type:
        • Adsorbable
        • Non-adsorbable
      • By Application:
        • Malignant Obstruction
        • Biliary Leaks
        • Benign Biliary Strictures
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Type:
        • Adsorbable
        • Non-adsorbable
      • By Application:
        • Malignant Obstruction
        • Biliary Leaks
        • Benign Biliary Strictures
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Type:
        • Adsorbable
        • Non-adsorbable
      • By Application:
        • Malignant Obstruction
        • Biliary Leaks
        • Benign Biliary Strictures
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Type:
        • Adsorbable
        • Non-adsorbable
      • By Application:
        • Malignant Obstruction
        • Biliary Leaks
        • Benign Biliary Strictures
        • Others
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
  • Company Profiles
    • C.R. Bard
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • AMG International
    • Boston Scientific
    • PNN Medical
    • Cook Medical
    • Taewoong Medical
    • Merit Medical
    • Teleflex

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements in Metal Non-covered Biliary Stents
    • Key Developments
    • Acquisition, Collaborations & Partnerships
    • Epidemiology
  4. Global Metal Non-covered Biliary Stent Market, Impact of Coronavirus (COVID-19) Pandemic
    • Pre-COVID situation
    • Post-COVID demand
    • Need for Metal Non-covered Biliary Stent
    • Recommendations and guidelines by regulatory bodies
  5. Global Metal Non-covered Biliary Stent Market, By Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Adsorbable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Non-adsorbable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Metal Non-covered Biliary Stent Market, By Application, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Malignant Obstruction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Biliary Leaks
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Benign Biliary Strictures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Others
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Metal Non-covered Biliary Stent Market, By End User, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Clinics
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  8. Global Metal Non-covered Biliary Stent Market, By Region, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027(%)
      • Y-o-Y Growth Analysis, By Region, 2017 –2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Company Profiles
      • amg International
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boston Scientific
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • R. Bard
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Cook Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merit Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • PNN Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Taewoong Medical
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Teleflex
        • Company Overview
        • Type Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 26 market data tables and 28 figures on "Global Metal Non-covered Biliary Stent Market” - Forecast to 2027”

Frequently Asked Questions

The global metal non-covered biliary stent market is expected to register a CAGR of 4.4% during the forecast period (2020-2027).
The global market for the metal non-covered biliary stent is estimated to be valued at US$ 326.31 million in 2020.
The prominent players in metal non-covered biliary stent market across the globe are Boston Scientific, AMG International, C.R. Bard, Merit Medical, Cook Medical, PNN Medical, Teleflex, and Taewoong Medical.
The metal non-covered biliary stent market is expected to be valued at US$ 440.70 million in 2027.
The major region in the metal non-covered biliary stent market is North America.
The increasing R&D funding, technological advancements, and the growing geriatric population are some of the key factors driving the market growth.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner